As the scenario may differ in tissue during inflammation, we additionally measured the expression of CD20 and other B-cell markers on T cells in the CSF of newly diagnosed untreated patients with relapsing-remitting multiple sclerosis (RRMS). The gene discussed is MS4A1; the disease is relapsing-remitting multiple sclerosis.